Rx for Growth: Greg Voyles Appointed to Accelerate Imre's Healthcare Mission

Voyles' appointment sets the stage for Imre's ability to deliver new solutions for healthcare clients navigating an era of rapid change and opportunity

NEW YORK, May 7, 2025 /PRNewswire/ -- Imre signals a bold new era of client-focused growth with the appointment of Greg Voyles as Chief Growth Officer. This appointment highlights Imre's commitment to continued growth as a healthcare agency-of-record across HCP and DTC assignments, with a focus on new offerings that harness Generative AI for marketing effectiveness in the rapidly evolving biopharma landscape.

"We're excited to welcome Greg to Imre. His deep commercial experience is a great match for our agency's proven track record of innovation in healthcare marketing for more personal engagement," said Anna Kotis, President. "At Imre, our mission is connecting people to brands for navigating life's most important decisions. As the tools and offerings that make these connections continue to evolve, Greg's experience across many sides of the customer equation can help brands be more nimble in adopting new ways to win and serve. He will play a key role as we steward our brands and business into this new Gen AI era in our industry."

Greg brings more than 25 years of pharmaceutical industry experience, with deep expertise spanning sales, marketing, and operations. In his role, Greg will lead the agency's growth strategy—overseeing business development, reputation management, and marketing initiatives.

Most recently, Greg spent six years at Syneos Health, where he delivered integrated commercial solutions for pharmaceutical brands across a range of therapeutic areas. Prior to that, he held senior leadership roles at both emerging and established healthcare companies, with titles including Chief Operating Officer at Vertical Pharmaceuticals and as Chief Commercial Officer at Osmotica Pharmaceutical. In these roles, he led product development, brand strategy, and national sales efforts, helping drive growth and navigate successful acquisitions.

"What drew me to Imre was the culture—it was clear from every conversation that this is a team driven by shared goals and a strong sense of purpose. That kind of alignment is essential for sustainable growth," said Voyles. "I'm excited to help propel Imre into its next phase as it doubles down on healthcare and precision data solutions to meet the unique client challenges of the day."

Earlier in his career, Greg held pivotal commercial leadership roles at global pharmaceutical companies, where he helped launch new divisions, built commercial operations from the ground up, and brought multiple products to market.

"My immediate focus is on listening—understanding our current growth processes and identifying what's already working well so we can build on that momentum. But just as important, I'm looking forward to getting to know the people behind the work and finding ways to support their growth, too," added Voyles.

About Imre:
Imre is a performance-driven creative agency that connects people to brands for life's most important decisions. With roots 32 years deep in the worlds of digital, social, and PR, Imre is a full-service agency-of-record (AOR) with an impressive roster of launch and lifecycle brands, including those in the healthcare and wellness spaces (including both HCP and DTC), led by a team of seasoned launch experts. Imre's innovative approaches span across creative, brand strategy, omnichannel marketing, AI optimization, modern earned, paid media, and the latest in data and analytics. Imre partners with a diversified and growing portfolio of healthcare and consumer organizations. The agency maintains offices in New York, Philadelphia, and Baltimore in addition to maintaining a work-from-anywhere culture. Imre is an LGBTQ-founded company.

SOURCE Imre